Donglai Wang

1.2k citations
30 papers · 956 indexed · h-index 14
Topics
Epigenetics and DNA Methylation (10 papers)Ubiquitin and proteasome pathways (8 papers)Cancer-related Molecular Pathways (7 papers)

In The Last Decade

Donglai Wang

28 papers receiving 949 citations

Peers

Donglai Wang
Comparison fields: 5 of 75
  • Molecular Biology 719
  • Epidemiology 233
  • Oncology 206
  • Cancer Research 149
  • Geriatrics and Gerontology 86
Replace Jiangxue Wu with:
Jiangxue Wu China
Yan Mo China
Qiqiang Guo China
James R. Knabb United States
Walid Mahfouf France
Ray-Whay Chiu Yen United States
Ruorong Yan China
Tomasz Rzymski Poland
Yang W. Zhang United States
Yanying Huo United States
Donglai Wang relative to Jiangxue Wu China Jiangxue Wu's profile →
Citations per field
00.5×1.5×2.2×
Jiangxue Wu · 1×
Citations per year

Countries citing papers authored by Donglai Wang

Since Specialization
Citations

This map shows the geographic impact of Donglai Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donglai Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donglai Wang more than expected).

Fields of papers citing papers by Donglai Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donglai Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donglai Wang. The network helps show where Donglai Wang may publish in the future.

Co-authorship network of co-authors of Donglai Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Donglai Wang. A scholar is included among the top collaborators of Donglai Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donglai Wang. Donglai Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 0
4 1
5 10
6 15
7 1
8 6
9 27
10 15
11 7
12 3
13 9
14 5
15 15
16 13
17 161
18 148
19
Identification and Biological Characteristics of Colletotrichum Gloeosporioides on Strawberry
3
20 6

About Donglai Wang

Donglai Wang is a scholar working on Molecular Biology, Oncology and Cancer Research, having authored 30 papers that have together received 956 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (10 papers), Ubiquitin and proteasome pathways (8 papers) and Cancer-related Molecular Pathways (7 papers). The work is most often cited by research in Geriatrics and Gerontology (86 citations), Molecular Biology (719 citations) and Aging (18 citations). Donglai Wang has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Wei‐Guo Zhu, Wei Gu, Ying Zhao, Lina Wang, Ning Kon, Haiying Wang, Le Jiang, Xiangyu Liu, Jingyi Zhou and Jun Qin. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026